Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man

Pain

Volumn 86, Issue 3, 2000, Pages 293-303

  Warncke, Torhild ^a   Stubhaug, Audun ^a   Jørum, Ellen ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Hyperalgesia; Ketamine; Morphine; NMDA receptor antagonist; Preemptive; Wind up

Indexed keywords

KETAMINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NARCOTIC ANALGESIC AGENT; PLACEBO;

ADULT; ANTINOCICEPTION; ARTICLE; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERALGESIA; MALE; NERVE CELL EXCITABILITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERMAL INJURY;

ADULT; ANALGESICS; ANALGESICS, OPIOID; BURNS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; INJECTIONS, INTRAVENOUS; KETAMINE; LEG; MALE; MORPHINE; PAIN; SENSORY THRESHOLDS; SKIN TEMPERATURE; TEMPERATURE SENSE; TOUCH;

EID: 0034213770     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(00)00260-8     Document Type: Article

References (59)

1. Århem P., Rydqvist B. The mechanism of action of ketamine on the myelinated nerve membrane. Eur J Pharmacol. 126:1986;245-251.
2. Arnèr S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
3. Baumann T.K., Simone D.S., Shain C.N., LaMotte R.H. Neurogenic hyperalgesia: the search for the primary cutaneous afferent fibers that contribute to capsaicin-induced pain and hyperalgesia. J Neurophysiol. 66:1991;212-227.
4. Campbell J.N., Meyer R.A. Primary afferents and hyperalgesia. Yaksh T. Afferent processing in the spinal cord. 1985;59-81 Plenum Press, New York.
5. Carlton S.M., Hargett G.L., Coggeshall R.E. Localization and activation of glutamate receptors in unmyelinated axons of glaborous skin. Neurosci Lett. 197:1995;25-28.
6. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
7. Coderre T.J., Katz J., Vaccarino A.L., Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain. 52:1993;259-285.
8. Conover W.J. Practical nonparametric statistics. 2nd ed :1980;Wiley, New York.
9. Cook A.J., Woolf C.J., Wall P.D., McMahon S.B. Expansion of cutaneous receptive fields of dorsal horn neurones following C-primary afferent fibre inputs. Nature. 325:1987;151-153.
10. Dahl J.B., Hansen B.L., Hjortsø N.C., Erichsen C.J., Møiniche S., Kehlet H. Influence of timing on the effect of continuous extradural analgesia with bupivacaine and morphine after major abdominal surgery. Br J Anaesth. 69:1992;4-8.
11. Davies S.N., Lodge D. Evidence for involvement of N-methyl-D-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res. 424:1987;402-406.
12. Dickenson A.H. Mechanisms of the analgesic actions of opiates and opioids. Br Med Bull. 47:1991;690-701.
13. Dickenson A.H. Where and how do opioids act? Gebhart G.F., Hammond D.L., Jensen T.S. Proceedings of the 7th World Congress on Pain. 1994;525-552 IASP Press, Seattle, WA.
14. Dickenson A.H., Sullivan A.F. Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn. Pain. 24:1986;211-222.
15. Dickenson A.H., Sullivan A.F. Subcutaneous formalin induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin. Pain. 30:1987;349-360.
16. Dickenson A.H., Sullivan A.F. Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C-fibre stimulation. Neuropharmacology. 26:1987;1235-1238.
17. Dierking G., Dahl J.B., Kanstrup J., Dahl A., Kehlet H. Effect of pre- vs postoperative inguinal field block on postoperative pain after herniorrhaphy. Br J Anaesth. 68:1992;344-348.
18. Dubner R., Ruda M.A. Activity dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
19. Eide P.K., Stubhaug A., Stenehjem A. Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurgery. 37:1995;1080-1087.
20. Grant I.S., Nimmo W.S., McNicol L.R., Clements J.A. Ketamine disposition in children and adults. Br J Anaesth. 55:1983;1107-1111.
21. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
22. Hardy J.D., Wolff G., Goodell H. Experimental evidence on the nature of cutaneous hyperalgesia. J Clin Invest. 29:1950;115-140.
23. 3 H-nitrendipine binding. Prog Clin Biol Res. 328:1990;469-472.
24. Ipe D. Performing the Friedman test and the associated multiple comparison test using PROC GLM. Proceedings of the Twelfth Annual SAS Users Group International Conference. 1987;SAS Institute, Cary, NY.
25. Katz J., Kavanagh B.P., Sandler A.N., Nierenberg H., Boylan J.F., Friedlander M., Shaw B.F. Preemptive analgesia: clinical evidence for neuroplasticity contributing to postoperative pain. Anaesthesiology. 77:1992;439-446.
26. LaMotte R.H., Thalhammer J.G., Torebjork H.E., Robinson C.J. Peripheral neural mechanisms of cutaneous hyperalgesia following mild injury by heat. J Neurosci. 6:1982;765-781.
27. LaMotte R.H., Shain C.N., Simone D.A., Tsai E.F. Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms. J Neurophysiol. 66:1991;190-211.
28. LaMotte R.H., Lundberg L.E.R., Torebjork H.E. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol. 448:1992;749-764.
29. Lascelles B.D.X., Waterman A.E., Cripps P.J., Livingston A., Henderson G. Central sensitisation as a result of surgical pain: investigation of the preemptive value of pethidine for ovariohysterectomy in the rat. Pain. 62:1995;201-212.
30. Lewis T. Experiments relating to cutaneous hyperalgesia and its spread through somatic nerves. Clin Sci. 2:1936;373-423.
31. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J Neurosci. 14:1994;2301-2312.
32. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995a;259-274.
33. Mao J., Price D.D., Phillips L.L., Lu J., Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677:1995b;257-267.
34. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995c;353-364.
35. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
36. McQuay H.J., Carrol D., Moore R.A. Postoperative orthopaedic pain - the effect of opiate premedication and local anaesthetic blocks. Pain. 33:1988;291-295.
37. Meyer R.A., Campbell J.N., Raja S.N. Peripheral neural mechanisms of nociception. Wall P.D., Melzack R. Textbook of pain. 1994;13-44 Churchill Livingstone, New York.
38. Nikolajsen L., Ilkjaer S., Christensen J.H., Krøner K., Jensen T.S. Randomised trial of epidural bupivacaine and morphine in prevention of stump and phantom pain in lower-limb amputation. Lancet. 350:1997;1353-1357.
39. Portenoy R.K., Foley K.M., Inturrisi C.E. The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain. 43:1990;273-286.
40. Pryle B.J., Vanner R.G., Enriquez N., Reynolds F. Can pre-emptive lumbar epidural blockade reduce postoperative pain following lower abdominal surgery? Br J Anaesth. 48:1993;120-123.
41. Raja S.N., Campbell J.N., Meyer R.A. Evidence for different mechanisms of primary and secondary hyperalgesia following heat injury to the glabrous skin. Brain. 107:1984;1179-1188.
42. Richmond C.E., Bromley L.M., Woolf C.J. Preoperative morphine pre-empts postoperative pain. Lancet. 342:1993;73-75.
43. Rowbotham M.C., Reisner-Keller L.A., Fields H.L. Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia. Neurology. 41:1991;1024-1028.
44. Schuttler J, Kloos S. IVA-SIM version 3.0, Bonn, 1991.
45. Shrivastav B.B. Mechanism of ketamine block of nerve conduction. J Pharmacol Exp Ther. 201:1977;162-170.
46. Stanski D.R., Greenblat D.J., Lowenstein E. Kinetics of intravenous and intramuscular morphine. Clin Pharm Ther. 24:1978;52-59.
47. Stubhaug A., Breivik H., Eide P.K., Kreunen M., Foss A. Mapping of punctuate hyperalgesia surrounding a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitisation to pain following surgery. Acta Anaesthesiol Scand. 41:1997;1124-1132.
48. Treede R.D., Meyer R.A., Srinivasa N.R., Campell J.N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 38:1992;397-421.
49. Tverskoy M., Oz Y., Isakson A., Finger J., Bradley E.L., Kissin I. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Analg Anesth. 78:1994;205-209.
50. Upton R.N., Semple T.J., Macintyre T.P.E. Pharmacokinetic optimisation of opioid treatment in acute pain therapy. Clin Pharmacokinet. 33:1997;225-244.
51. Warncke T, Stubhaug A, Jørum E. Preemptive treatment with morphine or ketamine inhibits development of secondary hyperalgesia in man, abstract nr. 113, 8th World Congress on Pain, Vancouver, Canada, 1996, p. 36.
52. Warncke T., Stubhaug A., Jørum E. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. Pain. 72:1997;99-106.
53. Warncke T., Jørum E., Stubhaug A. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine inhibits development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett. 227:1997;1-4.
54. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 306:1983;686-688.
55. Woolf C.J., Chong M.S. Preemptive analgesia - treating postoperative pain by preventing the establishment of central sensitisation. Anesth Analg. 77:1993;362-379.
56. Woolf C.J., Thompson S.W.N. The induction and maintenance of central sensitisation is dependent on N-methyl-D-aspartic acid receptor activity; implication for the treatment of postinjury pain hypersensitivity states. Pain. 44:1991;293-299.
57. Woolf C.J., Wall P.D. Morphine sensitive and morphine insensitive actions of C-fibre input on the rat spinal cord. Neurosci Lett. 64:1986;221-225.
58. Yamamoto T., Yaksh T.L. Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy. Neurosci Lett. 135:1992;67-70.
59. Zhou S., Bonasera L., Carlton S.M. Peripheral administration of NMDA, AMPA or KA results in pain behaviours in rats. NeuroReport. 7:1996;895-900.